Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2006 Sep 1;16(17):4629-32. Epub 2006 Jun 21.

Synthesis and evaluation of (2-phenethyl-2H-1,2,3-triazol-4-yl)(phenyl)methanones as Kv1.5 channel blockers for the treatment of atrial fibrillation.

Author information

1
Procter & Gamble Pharmaceuticals, Health Care Research Center, Mason, OH 45040, USA. bblass2@fuse.net

Abstract

A series of novel (2-phenethyl-2H-1,2,3-triazol-4-yl)(phenyl)methanones were prepared and examined for utility as Kv1.5 channel blockers for the treatment of atrial fibrillation.

PMID:
16793267
DOI:
10.1016/j.bmcl.2006.06.001
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center